Immunosenescence, multimorbidity, frailty and COVID-19
PDF (Español (España))

Keywords

Coronavirus
COVID-19
Fragilty
Immunosenescence
Multimorbidity
Sarcopenia

How to Cite

Gutiérrez Cortes, W. A. . (2021). Immunosenescence, multimorbidity, frailty and COVID-19 . Revista Endocrino, 8(1). https://doi.org/10.53853/encr.8.1.665

Abstract

Objective. The COVID-19 pandemic has caused a significant increase in hospitalizations and deaths from pneumonia with multi-organ disease. Taking into account that older persons have been the most affected by the pandemic and that their high mortality is due to conditions typical of advanced age such as frailty, Multimorbidity, and Immunosenescence, the author intends to briefly describe these variables and their relationship with mortality.

Methods. A systematic search was carried out in databases such as PubMed and Scopus, based on articles on immunosenescence, multimorbidity, frailty, and COVID-19 in the last year. The high-frequency MeSH terms were used, the terms were: Coronavirus, COVID-19, Frailty, Immunosenescence, Multimorbidity, Sarcopenia. A total of 500 articles were obtained, they were filtered by date, age, language, and type of article, obtaining 50 articles for review.

Discussion. COVID-19 poses a great threat to older persons. This is particularly true in people with frailty and multimorbidity.

Conclusion. It is recognized that the pandemic will require permanent efforts in an uncertain time frame, which is why different authors have drawn attention to four objectives: first, to do more clinical research in older persons, second, to link geriatricians for decision making, third, knowledge of the needs of vulnerable populations, and fourth emphasize the importance of person-centered approaches that promote respect for autonomy, justice, and beneficence.

https://doi.org/10.53853/encr.8.1.665
PDF (Español (España))

References

W. Joost Wiersinga, Andrew Rhodes, Allen C. Cheng, Sharon J. Peacock, Hallie C. Prescott. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19). A Review. JAMA. July 10, 2020. doi:10.1001/jama.2020.12839.

Roselli Diego. Covid-19 en Colombia: Los primeros 90 días. Acta Neurológica Colombiana. Junio 2020. https://doi.org/10.22379/24224022287.

Gutiérrez Cortes WA. Papel del geriatra colombiano ante la pandemia por COVID 19. Rev Esp Geriatr Gerontol. 2020. https://doi.org/10.1016/j.regg.2020.06.010.

Boletín Covid 19 En Colombia. INS. Recuperado de: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx.

Huang C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

Hewitt J. et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Heal [Internet]. 2020;0(0):1–8.

Dawei Bang, Bo Hu, Chang Hu. Outcomes M. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. 2020;323(11):1061–9.

C. Vellas, P. Delobel, P. De Souto Barreto, J. Izopet. COVID-19, Virology and Geroscience: A Perspective. J Nutr Health Aging. 2020;24(7):685-691.

La inmunosenescencia. Orientaciones y propuestas para un envejecimiento saludable. Información básica para personal del sector salud. Grupo de Inmunología y Medicina Traslacional. Facultad de Medicina - Universidad Nacional de Colombia. Bogotá – Colombia. Agosto de 2020.

Lozada-Requena Iván, Núñez Ponce Cesar. COVID-19: Respuesta inmune y perspectivas terapéuticas. Rev Peru Med Exp Salud Publica. 2020;37(2):312-9.

Wang F, Nie J, Wang H, Qiu Z, Yong X, Liping D, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020; doi: 10.1093/infdis/jiaa150. [Epub ahead of print].

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syn¬drome. Lancet Respir Med. 2020;2600(20):19–21. doi: 10.1016/S2213- 2600(20)30076-X.

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. J Chem Inf Model. 2020; doi: 10.1093/cid/ciaa248. [Epub ahead of print].

de la Rica R, Borges M and Gonzalez-Freire M (2020) COVID-19: In the Eye of the Cytokine Storm. Front. Immunol. 11:558898. doi: 10.3389/fimmu.2020.558898.

Leonardo Bencivenga & Giuseppe Rengo & Gilda Varricchi. Elderly at time of Coronavirus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition. GeroScience (2020) 42:1089–1092. https://doi.org/10.1007/s11357-020-00218-9.

Claudio Napoli, Isabella Tritto, Gelsomina Mansueto, Enrico Coscioni, Giuseppe Ambrosio. Immunosenescence exacerbates the COVID-19. Archives of Gerontology and Geriatrics 90 (2020) 104174. https://doi.org/10.1016/j.archger.2020.104174.

Eduardo Fuentes, Manuel Fuentes, Marcelo Alarcón1 and Iván Palomo. Immune System Dysfunction in the Elderly. Annals of the Brazilian Academy of Sciences (2017) 89(1): 285-299. http://dx.doi.org/10.1590/0001-3765201720160487.

Seilesh Kadambari, Paul Klenerman, Andrew J. Pollard. Why the elderly appear to be more severely affected by COVID-19: The potential role of Immunosenescence and CMV. Rev Med Virol. 2020;e2144. https://doi.org/10.1002/rmv.2144.

Cunha LL, Perazzio SF, Azzi J, Cravedi P and Riella LV. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response. Front. Immunol. 11:1748. doi: 10.3389/fimmu.2020.01748.

Judy Chen, William J. Kelley and Daniel R. Goldstein. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19. J Immunol 2020; 205:313-320; Prepublished online 3 June.

La edad y estas enfermedades aumentan el riesgo de morir por covid-19. Recuperado: https://www.eltiempo.com/salud/coronavirus-colombia-hoy-estas-son-las-enfermedades-ligadas-a-las-muertes-por-covid-19-518600.

Belloni G and Cesari M (2019) Frailty and Intrinsic Capacity: Two Distinct but Related Constructs. Front. Med. 6:133.doi: 10.3389/fmed.2019.00133.

Vermeiren S, Vella-Azzopardi R, Beckwée D, Habbig AK, Scafoglieri A, Jansen B, et al. Frailty and the prediction of negative health outcomes: a meta-analysis. J Am Med Dir Assoc. (2016) 17:1163.e1–17.doi:10.1016/j.jamda.2016.09.010.

Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013;14:392–7.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol SciMed Sci. (2001) 56:M146–156. doi:10.1093/gerona/56.3.m146.

Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ Can Med Assoc J J Assoc Medicale Can. (2005) 173:489–95. doi:10.1503/cmaj.050051.

Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. (2016) 31:3–10. doi: 10.1016/j.ejim.2016.03.007.

Melissa Shears, Alyson Takaoka, Bram Rochwerg, Sean M. Bagshaw, Jennie Johnstone, Amanda Holding, Surenthar Tharmalingam, Tina Millen, France Clarke, Kenneth Rockwood, Guowei Li, Lehana Thabane, John Muscedere, Thomas T. Stelfox, Deborah J. Cook, Canadian Critical Care Trials Group, Assessing frailty in the intensive care unit: A reliability and validity study. Yjcrc(2017), https://doi.org/10.1016/j.jcrc.2018.02.004.

Hope AA, Hsieh SJ, Petti A, Hurtado-Sbordoni M, Verghese J, Gong MN. Assessing the Usefulness and Validity of Frailty Markers in Critically Ill Adults. Annals of the American Thoracic Society 2017;14(6):952-9.

Bandeen-Roche K, Seplaki CL, Huang J, et al. Frailty in older adults: a nationally representative profile in the United States. J Gerontol A Biol Sci Med Sci 2015;70:1427–34.

Xue QL, Buta B, Varadhan R, et al. Frailty and geriatric syndromes. In: Satariano WA, Maus M, editors. Aging, place, and health: a global perspective. Burlington (MA): Jones & Bartlett Learning; 2017. p. 191–230.

Gómez Montes JF, Curcio Borrero CL, Henao GM. Fragilidad En Ancianos Colombianos. Rev Medica Sanitas. 2012;15(4):8–16.

Muscedere J, Waters B, Varambally A, et al. The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive Care Med. 2017;43(8):1105-1122.

Brummel NE, Bell SP, Girard TD, Pandharipande PP, Jackson JC, Morandi A, Thompson JL, Chandrasekhar R, Bernard GR, Dittus RS, Gill TM, Ely EW (2016) Frailty and subsequent disability and mortality among patients with critical illness. Am J Respir Crit Care Med. doi:10.1164/ rccm.201605- 0939OC.

Kizilarslanoglu MC, Civelek R, Kilic MK, Sumer F, Varan HD, Kara O, Arik G, Turkoglu M, Aygencel G, Ulger Z (2017) Is frailty a prognostic factor for critically ill elderly patients? Aging Clin Exp Res 29:247– 255mu.

NICE https://www.nice.org.uk/guidance/ng159/resources/critical-care-admission-algorithm-pdf-87089488934 acceso 11 de abrilde 2020.

Hewitt J, Carter B, Vilches-Moraga A, Quinn TJ, Braude P, Verduri A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Heal [Internet]. 2020;0(0):1–8. Disponible en:: https://linkinghub.elsevier.com/retrieve/pii/S2468266720301468.

Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, et al. Sarcopenia: a time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle 2019;10:956–961.

Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Krithevsky SB, Guralnik J, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging 2018;22:1148–1161.

Wandrag L, Siervo M, Riley HL, Khosravi M, Fernandez BO, Leckstrom CA, et al. Dose hypoxia play a role in the development of sarcopenia in humans? Mechanistic insights from the Caudwell Xtreme Everest expedition. Redox Biol 2017;13:60–68.

Gutiérrez William A, Martinez Fhara E, Olaya Laura C. Sarcopenia, una patología nueva que impacta a la vejez. Revista Colombiana de Endocrinología, Diabetes y Metabolismo. Volumen 5, número 1, febrero de 2018.

Izquierdo M, Rodriguez-Mañas L, Sinclair AJ. Editorial: what is new in exercise regimes for frail older people – how does the Erasmus Vivifrail project take us forward? J Nutr Health Aging. 2016;20:736–737.

Izquierdo M, Morley JE, Lucia A. Exercise in people over 85. BMJ 2020;368:m402.

Li J. Effect and enlightenment of rehabilitation medicine in COVID-19 management. Eur J Phys Rehabil Med 2020. (Epub ahead of print).

John E. Morley, Kamyar Kalantar-Zadeh & Stefan D. Anker. COVID-19: a major cause of cachexia and sarcopenia?. Journal of Cachexia, Sarcopenia and Muscle 2020; 11: 863–865. Published online 9 June 2020 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/jcsm.12589.

John e. Morley. Covid-19 and older adults. The journal of nutrition, health & aging. 2020; 24 (4); 364-365.

Haffajee RL, Mello MM. Thinking globally, acting locallydthe U.S. response to COVID-19. N Engl J Med 2020;382:e75.

Landi F., Barillaro C., Bellieni A., et al. The new challenge of geriatrics: Saving frail older people from the SARS-CoV-2 pandemic infection. J Nutr Health Aging 2020;24:466e470.

Lloyd-Sherlock PG, Kalache A, McKee M, et al. WHO must prioritise the needs of older people in its response to the covid-19 pandemic. BMJ 2020;368:m1164.

Christopher C. Colenda, MD, MPH et al. Covid-19 Pandemic and Ageism: a Call for Humanitarian Care. JAGS. Editorial month 2020-vol. 00, no.00.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.